Lignocaine Anaesthetics Injection Pack - Schedule 4 Medicine
Healthcare professionals ONLY. Not available to the general public.
Limited product information due to pharmaceutical compliance requirements.
Lignocaine Anaesthetics Injection Pack is a prescription-only pharmaceutical product supplied for use by authorised healthcare professionals. This product is classified as a Schedule 4 medicine in Australia and requires appropriate authorisation before supply.
Alpha Medical Solutions provides pharmaceutical products Australia-wide to eligible healthcare providers with approved accounts.
Active Ingredient
The active ingredient is lignocaine hydrochloride, supplied as a solution for injection. For complete ingredient information, including excipients, please refer to the manufacturer's approved Product Information (PI) and product packaging.
Features
- Sterile ampoules
- Available in multiple concentrations and pack sizes
- Manufacturer-sealed packaging
Pharmaceutical Scheduling & Compliance
Lignocaine Anaesthetics Injection is classified as a Schedule 4 (Prescription Only Medicine) under Australian scheduling requirements.
Access is restricted to authorised healthcare professionals. A valid Alpha Medical Solutions account and appropriate verification may be required before supply.
Excipients & Known Allergens
Information regarding excipients, ingredients, and potential allergens should be reviewed in the approved product documentation supplied with the medicine.
Product Specifications
| Product | Lignocaine Anaesthetics Injection Pack |
| Active Ingredient | Lignocaine Hydrochloride |
| Schedule | Schedule 4 Medicine |
| Product Type | Prescription pharmaceutical product |
Pack Size & Packaging
The Lignocaine Anaesthetics Injection Pack is supplied in manufacturer-sealed sterile ampoules. Available concentrations, ampoule volumes, and pack sizes vary by SKU. Please refer to the table below for the available product configurations. For complete product specifications, refer to the manufacturer's approved Product Information (PI) and product packaging.
| SKU | Concentration | Ampoule Volume | Pack Size (Ampoules) |
| SCH4-JUNF000060944-P | 1% | 5mL | 50 |
| SCH4-JUNF000060955-P | 2% | 5mL | 50 |
| SCH4-JUNF000060892-P | 1% | 20mL | 30 |
| SCH4-JUNF000060899-P | 2% | 20mL | 30 |
Storage & Shelf Life
Storage conditions and shelf life should be checked according to the product packaging and manufacturer's documentation.
PBS Listing Information
PBS listing information may vary depending on product details and prescribing requirements. Healthcare professionals should refer to current PBS information where applicable.
Important Ordering Information
Dear Customer,
Thanks for visiting our store.
Please note that you need to have the necessary authorisation to receive scheduled substances. Please fill out this FORM so that we can verify and confirm your eligibility to activate your account and process your order.
The schedule is designed to protect public health and safety. Some medicines have a higher risk of causing harm than others. Some medicines may also require additional controls due to their potential for misuse.
All deliveries are to be made to the practice address and not to the place of residence.
We appreciate your understanding.
Frequently Asked Questions (FAQs)
What is Lignocaine Anaesthetic Injection?
Lignocaine Anaesthetics Injection is a prescription pharmaceutical product containing lignocaine and supplied for authorised healthcare professional use.
Is Lignocaine Injection available to the general public?
No. Lignocaine Anaesthetics Injection is a Schedule 4 medicine and is not available to the general public.
Is Lignocaine Injection a Schedule 4 medicine?
Yes. Lignocaine Injection is classified as a Schedule 4 (Prescription Only Medicine) in Australia.
Who can access Lignocaine Anaesthetic Injection?
Supply is restricted to authorised healthcare professionals with appropriate verification and account approval.
| Anaesthetics | Local |
| Range | Anaesthetics |